The direct thrombin inhibitor melagatran/ximelagatran

Med J Aust. 2005 Mar 7;182(5):254-5. doi: 10.5694/j.1326-5377.2005.tb06686.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticoagulants / economics
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications
  • Azetidines / economics
  • Azetidines / therapeutic use*
  • Benzylamines / economics
  • Benzylamines / therapeutic use*
  • Cost-Benefit Analysis
  • Drug Costs
  • Humans
  • Safety
  • Thrombin / antagonists & inhibitors*
  • Thromboembolism / prevention & control
  • Warfarin / economics
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Azetidines
  • Benzylamines
  • melagatran
  • ximelagatran
  • Warfarin
  • Thrombin